omniture
上海药明康德新药开发有限公司 SHANGHAI PHARMATECHS CO.LTD

Latest News

Statement by WuXi AppTec Regarding Recent Market Fluctuation

SHANGHAI, Dec. 15, 2021 /PRNewswire/ -- Our company's activities continue apace and we remain confi...

2021-12-16 08:00 1606

WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan

SHANGHAI, Dec. 8, 2021 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufactur...

2021-12-09 08:00 934

WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers

PHILADELPHIA, Oct. 17, 2021 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a wholly owne...

2021-10-18 11:05 775

WuXi AppTec Receives AA ESG Rating from MSCI

SHANGHAI, Sept. 5, 2021 /PRNewswire/ -- WuXi AppTec ("the Company") is pleased to announce that Mor...

2021-09-06 08:00 1531

WuXi AppTec Reports Strong 2021 Interim Results

* Revenue Up 45.7% Year-Over-Year to RMB10,537 Million * Net Profit Attributable to Owners of th...

2021-08-12 17:52 2106

WuXi AppTec Reports Strong 2020 Annual Results

Revenue Up 28.5% Year-over-Year to RMB16,535 Million Net Profit Attributable to Owners of the Compan...

2021-03-30 21:10 1615

WuXi AppTec Recognized by Frost & Sullivan with 2020 Global Customer Value Leadership Award

SHANGHAI, Dec. 2, 2020 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufactur...

2020-12-03 08:00 1031

ViGeneron and WuXi Advanced Therapies Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy

PHILADELPHIA and MUNICH, Dec. 1, 2020 /PRNewswire/ -- ViGeneron, a gene therapy company, and WuXi A...

2020-12-01 21:00 1469

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-The-Art Testing Laboratory

PHILADELPHIA, Nov. 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a business un...

2020-11-18 21:00 1007

WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations

WuXi AppTec Second-Quarter 2020 Results Revenue Up 29.4% YoY to RMB4,044 Million Net Profit Attribu...

2020-08-13 16:49 4258

WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia

SHANGHAI and SAN DIEGO, July 9, 2020 /PRNewswire/ -- WuXi AppTec is pleased to announce that they a...

2020-07-09 16:32 1069

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

PHILADELPHIA, May 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Devel...

2020-05-18 21:00 1300

WuXi AppTec Reports Solid First-Quarter 2020 Results

SHANGHAI, April 29, 2020 /PRNewswire/ -- WuXi AppTec Co., Ltd. (stock code: 603259.SH / 2359.HK), a...

2020-04-29 17:30 8211

WuXi AppTec Reports Strong 2019 Annual Results

Revenue Growth Accelerated 33.9% Year-Over-Year to RMB12,872 Million Adjusted Non-IFRS Net Profit At...

2020-03-24 18:56 6062

WuXi AppTec Wuhan Site Resumes Operation

SHANGHAI, March 11, 2020 /PRNewswire/ -- WuXi AppTec announced today that the company'sWuhan site h...

2020-03-11 20:00 1122

WuXi AppTec China Sites Resume Operations after Extended Lunar New Year Holiday

SHANGHAI, Feb. 12, 2020 /PRNewswire/ -- With the end of the extended Lunar New Year holiday, WuXi A...

2020-02-12 20:00 906

WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform

PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Deve...

2020-01-13 22:00 5721

WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility

SHANGHAI, Jan. 2, 2020 /PRNewswire/ -- STA Pharmaceutical Co., Ltd.,  (W...

2020-01-03 08:10 1353

WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies

SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- WuXi AppTec announced today that it has received investment ...

2019-11-06 16:00 657

WuXi STA's Jinshan Facility Passes EMA Inspection

SHANGHAI, Oct. 28, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of ...

2019-10-28 08:00 1723
1234